<VariationArchive VariationID="657663" VariationName="NM_001048174.2(MUTYH):c.192dup (p.Val65fs)" VariationType="Duplication" Accession="VCV000657663" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2019-08-14" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="628102" VariationID="657663">
      <GeneList>
        <Gene Symbol="MUTYH" FullName="mutY DNA glycosylase" GeneID="4595" HGNC_ID="HGNC:7527" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45329242" stop="45340440" display_start="45329242" display_stop="45340440" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45794913" stop="45806141" display_start="45794913" display_stop="45806141" Strand="-" />
          </Location>
          <OMIM>604933</OMIM>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001048174.2(MUTYH):c.192dup (p.Val65fs)</Name>
      <CanonicalSPDI>NC_000001.11:45333484:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p34.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="45333484" stop="45333485" display_start="45333484" display_stop="45333485" variantLength="1" positionVCF="45333484" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="45799156" stop="45799157" display_start="45799156" display_stop="45799157" variantLength="1" positionVCF="45799156" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>V76fs</ProteinChange>
      <ProteinChange>V80fs</ProteinChange>
      <ProteinChange>V93fs</ProteinChange>
      <ProteinChange>V90fs</ProteinChange>
      <ProteinChange>V66fs</ProteinChange>
      <ProteinChange>V65fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.45333486dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.45333486dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008189.1" sequenceAccession="NG_008189" sequenceVersion="1" change="g.11986dup">
            <Expression>NG_008189.1:g.11986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048171.2" sequenceAccession="NM_001048171" sequenceVersion="2" change="c.192dup">
            <Expression>NM_001048171.2:c.192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041636.2" sequenceAccession="NP_001041636" sequenceVersion="2" change="p.Val65fs">
            <Expression>NP_001041636.2:p.Val65fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048172.2" sequenceAccession="NM_001048172" sequenceVersion="2" change="c.195dup">
            <Expression>NM_001048172.2:c.195dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041637.1" sequenceAccession="NP_001041637" sequenceVersion="1" change="p.Val66fs">
            <Expression>NP_001041637.1:p.Val66fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048173.2" sequenceAccession="NM_001048173" sequenceVersion="2" change="c.192dup">
            <Expression>NM_001048173.2:c.192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041638.1" sequenceAccession="NP_001041638" sequenceVersion="1" change="p.Val65fs">
            <Expression>NP_001041638.1:p.Val65fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001048174.2" sequenceAccession="NM_001048174" sequenceVersion="2" change="c.192dup" MANESelect="true">
            <Expression>NM_001048174.2:c.192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001041639.1" sequenceAccession="NP_001041639" sequenceVersion="1" change="p.Val65fs">
            <Expression>NP_001041639.1:p.Val65fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128425.2" sequenceAccession="NM_001128425" sequenceVersion="2" change="c.276dup" MANEPlusClinical="true">
            <Expression>NM_001128425.2:c.276dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121897.1" sequenceAccession="NP_001121897" sequenceVersion="1" change="p.Val93fs">
            <Expression>NP_001121897.1:p.Val93fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293190.2" sequenceAccession="NM_001293190" sequenceVersion="2" change="c.237dup">
            <Expression>NM_001293190.2:c.237dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280119.1" sequenceAccession="NP_001280119" sequenceVersion="1" change="p.Val80fs">
            <Expression>NP_001280119.1:p.Val80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293191.2" sequenceAccession="NM_001293191" sequenceVersion="2" change="c.225dup">
            <Expression>NM_001293191.2:c.225dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280120.1" sequenceAccession="NP_001280120" sequenceVersion="1" change="p.Val76fs">
            <Expression>NP_001280120.1:p.Val76fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293192.2" sequenceAccession="NM_001293192" sequenceVersion="2" change="c.-85dup">
            <Expression>NM_001293192.2:c.-85dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293195.2" sequenceAccession="NM_001293195" sequenceVersion="2" change="c.192dup">
            <Expression>NM_001293195.2:c.192dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001280124.1" sequenceAccession="NP_001280124" sequenceVersion="1" change="p.Val65fs">
            <Expression>NP_001280124.1:p.Val65fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001293196.2" sequenceAccession="NM_001293196" sequenceVersion="2" change="c.-85dup">
            <Expression>NM_001293196.2:c.-85dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350650.2" sequenceAccession="NM_001350650" sequenceVersion="2" change="c.-80dup">
            <Expression>NM_001350650.2:c.-80dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001350651.2" sequenceAccession="NM_001350651" sequenceVersion="2" change="c.-80dup">
            <Expression>NM_001350651.2:c.-80dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012222.3" sequenceAccession="NM_012222" sequenceVersion="3" change="c.267dup">
            <Expression>NM_012222.3:c.267dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036354.1" sequenceAccession="NP_036354" sequenceVersion="1" change="p.Val90fs">
            <Expression>NP_036354.1:p.Val90fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_146882.2" sequenceAccession="NR_146882" sequenceVersion="2" change="n.420dup">
            <Expression>NR_146882.2:n.420dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_146883.2" sequenceAccession="NR_146883" sequenceVersion="2" change="n.343dup">
            <Expression>NR_146883.2:n.343dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_220" sequenceAccession="LRG_220">
            <Expression>LRG_220:g.11986dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128425.1" sequenceAccession="NM_001128425" sequenceVersion="1" change="c.276dupA">
            <Expression>NM_001128425.1:c.276dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.45799158dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.45799158dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1570443585" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001048174.2(MUTYH):c.192dup (p.Val65fs) AND Familial adenomatous polyposis 2" Accession="RCV000814319" Version="4">
        <ClassifiedConditionList TraitSetID="1473">
          <ClassifiedCondition DB="MedGen" ID="C3272841">Familial adenomatous polyposis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001048174.2(MUTYH):c.192dup (p.Val65fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002433972" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-07" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-08-14" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18534194</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20663686</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1532" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MUTYH-related attenuated familial adenomatous polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUTYH-associated polyposis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adenomas, multiple colorectal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FAP type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial adenomatous polyposis 2</ElementValue>
                <XRef ID="MONDO:0012041" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYH-associated polyposis</ElementValue>
                <Citation Type="review" Abbrev="Lindor, 2011">
                  <ID Source="PubMed">21325953</ID>
                </Citation>
                <XRef ID="MYH-associated+polyposis/8937" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FAP2</ElementValue>
                <XRef Type="MIM" ID="608456" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MAP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">MUTYH polyposis (also referred to as MUTYH-associated polyposis, or MAP) is characterized by a greatly increased lifetime risk of colorectal cancer (CRC). Although typically associated with ten to a few hundred colonic adenomatous polyps, CRC develops in some individuals in the absence of polyposis. Serrated adenomas, hyperplastic/sessile serrated polyps, and mixed (hyperplastic and adenomatous) polyps can also occur. Duodenal adenomas are common, with an increased risk of duodenal cancer. The risk for malignancies of the ovary and bladder is also increased, and there is some evidence of an increased risk for breast and endometrial cancer. Additional reported features include thyroid nodules, benign adrenal lesions, jawbone cysts, and congenital hypertrophy of the retinal pigment epithelium.</Attribute>
                <XRef ID="NBK107219" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10805" />
                <XRef ID="10805" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987420</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23035301</ID>
                <ID Source="BookShelf">NBK107219</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO/ESMO, 2015">
                <ID Source="PubMed">25452455</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24310308</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Familial-Adenomatous-Polyposis-ACT-Sheet.aspx</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APC Pathogenic Variants (Familial Adenomatous Polyposis [FAP]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/cg118</URL>
                <CitationText>UK NICE Clinical Guideline CG118, Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="220460" DB="Orphanet" />
              <XRef ID="247798" DB="Orphanet" />
              <XRef ID="C3272841" DB="MedGen" />
              <XRef ID="MONDO:0012041" DB="MONDO" />
              <XRef Type="MIM" ID="608456" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1848904" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5234087|MedGen:C1837991" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000954723" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18534194</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20663686</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val93Serfs*28) in the MUTYH gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in MUTYH are known to be pathogenic (PMID: 18534194, 20663686). This variant has not been reported in the literature in individuals with MUTYH-related disease. This variant is not present in population databases (ExAC no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MUTYH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.45799156_45799157insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1837991" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5232016" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a8291535|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002747197" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.276dupA variant, located in coding exon 3 of the MUTYH gene, results from a duplication of A at nucleotide position 276, causing a translational frameshift with a predicted alternate stop codon (p.V93Sfs*28). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MUTYH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128425.1:c.276dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1848904" TraitType="Disease" MappingType="XRef" MappingValue="C1837991" MappingRef="MedGen">
        <MedGen CUI="C3272841" Name="Familial adenomatous polyposis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5232016" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

